By Robert Preidt
FRIDAY, Feb. fourteen, 2020 (HealthDay News) — Medication that quite a few men with prostate most cancers might now be getting — cholesterol-reducing statins — may perhaps aid extend their survival if they have a “superior-chance” form of the disorder, new investigate suggests.
Substantial-chance individuals contain men with superior blood amounts of prostate distinct antigen (PSA) and a “Gleason rating” of 8 or far more. Gleason scores are a calculation utilized to gauge prognosis in prostate most cancers. Males with a superior Gleason rating may perhaps develop challenging-to-address cancers.